Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Yu Liu

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Biology|August 6, 2021
Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial CarcinomaPei-Jhang Chiang, Ting Xu, Tai-Lung Cha, et al.
Journal of the Chinese Medical Association : JCMA|October 26, 2021
Detection of circulating tumor cells as therapeutic markers in patients with penile squamous cell carcinoma: A preliminary studyChien-Chang Kao, Ting Xu, Yung-Ning Yang, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 8, 2022
Determining programmed cell death ligand 1 expression in circulating tumor cells of patients with clear cell renal cell carcinoma and its correlation with response to programmed cell death protein 1 inhibitorsBo-Han Chen, Chien-Chang Kao, Ting Xu, et al.
Journal of Clinical Medicine|April 23, 2022
Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid TumorsChien-Chang Kao, Ching-Liang Ho, Ming-Hsin Yang, et al.
Cell Death & Disease|December 1, 2020
(D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse modelChing-Chi Chiu, Yi-Hsin Weng, Ying-Zu Huang, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Biology|August 6, 2021
Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial CarcinomaPei-Jhang Chiang, Ting Xu, Tai-Lung Cha, et al.
Journal of the Chinese Medical Association : JCMA|October 26, 2021
Detection of circulating tumor cells as therapeutic markers in patients with penile squamous cell carcinoma: A preliminary studyChien-Chang Kao, Ting Xu, Yung-Ning Yang, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 8, 2022
Determining programmed cell death ligand 1 expression in circulating tumor cells of patients with clear cell renal cell carcinoma and its correlation with response to programmed cell death protein 1 inhibitorsBo-Han Chen, Chien-Chang Kao, Ting Xu, et al.
Journal of Clinical Medicine|April 23, 2022
Phase I Targeted Combination Trial of Sorafenib and GW5074 in Patients with Advanced Refractory Solid TumorsChien-Chang Kao, Ching-Liang Ho, Ming-Hsin Yang, et al.
Cell Death & Disease|December 1, 2020
(D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse modelChing-Chi Chiu, Yi-Hsin Weng, Ying-Zu Huang, et al.
Pageof 6